Merck & Co. delivered robust fourth-quarter results, beating analyst estimates, but its full-year guidance fell short of Wall Street expectations, sending shares lower. The outlook incorporates significant charges from its recent acquisition of Cidara Therapeutics.
Strong quarterly results and bullish guidance from data analytics firm Palantir Technologies have fueled a pre-market surge in tech stocks, setting a positive tone for Wall Street as investors digest mixed economic signals and await key earnings reports.
Facing domestic funding pressures, Saudi Arabia is ramping up efforts to attract foreign capital through debt markets, equity reforms, and FDI, positioning itself as a top EM dollar debtor.
Financial technology giant Broadridge Financial Solutions (NYSE: BR) reported fourth-quarter revenue and profit that comfortably exceeded Wall Street forecasts, driven by resilient demand for its core transaction processing and investor communications services.
As a federal investigation into a quarter-billion-dollar pandemic feeding program fraud unfolds, Minnesota Attorney General Keith Ellison finds his progressive environmental litigation alliances facing renewed and intense political examination.
Industrial supplies giant W.W. Grainger (NYSE:GWW) reported fourth-quarter revenue that edged past Wall Street forecasts, though earnings per share fell short of consensus. The company's outlook suggests a period of moderated growth ahead.
Electrical safety products manufacturer Atkore (NYSE: ATKR) reported fourth-quarter revenue that surpassed Wall Street estimates, though sales remained unchanged year-over-year. Adjusted earnings significantly exceeded analyst projections, highlighting a mixed performance against a challenging industrial backdrop.
Despite a modest year-to-date rebound, Conagra Brands' stock continues to trail the broader market significantly, with Wall Street analysts expressing caution over persistent industry headwinds and muted growth prospects.
Specialty materials maker ATI (NYSE: ATI) saw its shares surge after reporting fourth-quarter earnings that topped estimates, even as revenue came in slightly below Wall Street forecasts. The company pointed to strong demand in aerospace and defense as a key driver.
Electrical equipment maker Hubbell (NYSE:HUBB) reported fourth-quarter sales of $1.49 billion, aligning with Wall Street estimates, though underlying organic growth signals a moderation in demand.
The maker of SuperPretzel and ICEE brands reported quarterly sales of $343.8 million, falling short of Wall Street forecasts and marking a year-over-year decline. Adjusted earnings also missed analyst expectations.
PayPal Holdings Inc. reported fourth-quarter revenue that fell short of Wall Street expectations, sending its stock plunging nearly 15% and raising questions about the digital payments pioneer's growth trajectory in a competitive market.
While Crown Castle's stock has lagged behind major indices, a 'Moderate Buy' consensus from Wall Street points to optimism for the telecom REIT's long-term fiber and 5G infrastructure play.
Pfizer reported fourth-quarter revenue and profit that topped Wall Street forecasts, yet year-over-year sales dipped slightly. The pharmaceutical giant's results highlight the ongoing challenge of moving beyond its COVID-19 windfall.
Despite a strong 52-week performance and a key new partnership with Worldpay, Regions Financial's stock is met with a tepid 'Hold' consensus from Wall Street, highlighting the complex sentiment surrounding regional banks.
Merck & Co. projected 2026 revenue below Wall Street expectations, citing a steeper-than-anticipated impact from patent expirations on key drugs like Januvia. The forecast overshadowed a strong Q4 performance driven by its blockbuster cancer therapy, Keytruda.
Analysts have lifted Man Group's fair value estimate, reflecting a cautiously optimistic recalibration of growth and risk assumptions. The move aligns with a broader trend of upward revisions across the Street, though questions remain about how much future performance is already priced into the stock.
The infrastructure giant has been awarded a seven-year contract to maintain over 5,000km of roads and 55,000 streetlights across Coventry, Solihull, and Warwickshire, with an option to extend the partnership to 2039.
Amid escalating trade tensions and tariff threats from the Trump administration, longstanding U.S. partners are accelerating negotiations with each other, seeking to reduce economic dependence on Washington. This shift towards diversification could erode U.S. influence and has already contributed to a weakening dollar, raising concerns about long-term financial stability.
CarGurus executives signal strategic investment push at a recent conference, forecasting a margin dip for 2026 to fuel long-term growth, leaving Wall Street analysts divided on the stock's near-term trajectory.
